S. Harrison et al., Stimulation of airway sensory nerves by cyclosporin A and FK506 in guinea-pig isolated bronchus, BR J PHARM, 125(7), 1998, pp. 1405-1412
1 We have investigated the contractile property of cyclosporin A. and FK506
in guinea-pig isolated bronchus.
2 Cyclosporin A (10 mu M) failed to significantly attenuate the excitatory
non-adrenergic non-cholinergic (eNANC) and cholinergic contractile response
(per cent methacholine E-max) induced by electrical held stimulation (EFS)
. In contrast, eNANC responses were significantly attenuated by both the ne
urokinin (NK)-1 and (NK)-2 receptor antagonists, N-acetyl-L-tryptophan 3,5-
bis (trifluoromethyl)-benzyl and SR48968, respectively.
3 Cyclosporin A and FK506 caused a concentration-dependent contraction in g
uinea-pig isolated bronchus, which was significantly attenuated by NK-1 and
NK-2 receptor antagonists. The capsaicin receptor antagonist, capsazepine
(10 mu M) significantly reduced the contractile response to cyclosporin A a
nd capsaicin, but not to FK506.
4 The N-type calcium channel blocker, omega-Conotoxin (omega CTX: 10 nM), s
ignificantly reduced the contractile response to FK506 and the eNANC respon
se following EFS. In contrast, omega-CTX failed to significantly reduce the
contractile potency to capsaicin or cyclosporin A.
5 In bronchial preparations desensitized by repeated application of capsaic
in (1 mu M), the contractile responses to both cyclosporin A (100 mu M) and
FK506 (100 mu M), were significantly reduced. In contrast, the contractile
responses to substance P and neurokinin A (10 mu M) were not altered. Furt
hermore, repeated application of cyclosporin A (100 mu M) significantly inh
ibited the contractile response to capsaicin (1 mu M).
6 The findings from this study would indicate that cyclosporin A and FK506
mediate contraction of guinea-pig isolated bronchus secondary to the releas
e of neuropeptides from airway sensory nerves. However, the release of sens
ory neuropeptides appears to be mediated via different mechanisms for cyclo
sporin A and FK506, the former by stimulation of the vanilloid receptor and
the latter via opening of N-type calcium channels.